Search results for: Market Access
Filter search results
Presentations from EuHEA 2018
2 August 2018
…Key factors driving access and uptake of hepatitis C treatments in Europe. Results from experts interviews from Office of Health Economics The Value of Targeted Sequencing in Advanced Cancer:…
Two New Papers on EQ-5D-5L Valuation in Ireland
21 August 2018
…values, including qualitative work undertaken by UAE University in collaboration with OHE. Both papers are available open access. Further outputs from this programme of work will be made available over…
OHE Lunchtime Seminar: The People’s Prescription – Re-imagining Health Innovation to Deliver Public Value
7 September 2018
…address public health needs or ensure access to new treatments and cures for the people that need them. The current health innovation system risks becoming just that: beleaguered by increasing…
OHE’s Annual Report to the Charity Commission 2017
16 November 2018
…that there is an important role for OHE’s work. We are confident that OHE will continue to grow in stature, reputation and impact. The full report can be accessed here….
New Publications: Real-World Evidence for Coverage and Formulary Decisions
7 December 2018
…Journal of Comparative Effectiveness Research and are available open access. The first article, led by Grace Hampson and Adrian Towse, is titled Real-world evidence for coverage decisions: opportunities and challenges….
Professor Mireia Jofre-Bonet Appointed Vice President and Head of Research
8 January 2019
…involved, building off existing synergies and creating new ones.”. Further information on Mireia is available on the OHE website. You can access Mireia’s publications via Google Scholar, ResearchGate and RePec …
OHE Lunchtime Seminar: What Can NHS Trusts do to Reduce Cancer Waiting Times?
10 January 2019
…Rapid diagnosis and access to treatment for cancer are vital for both clinical outcomes and patient experience of care. The NHS Constitution contains several waiting times targets, including that 85%…
End of Life Treatments, Societal Values, and ‘Overall’ Preference
12 February 2019
…part of the London Health Economics Group series. Access Koonal’s slides below. End of life treatments, societal values, and selecting a measure of ‘overall’ preference from Office of Health Economics…
Abolishing Pharmaceutical Rebates in the US? Looking at the Trade-Offs
12 March 2019
…be downloaded from the ICER website here. Cole, A., Towse, A., Segel C.S., Henshall, C., Pearson, S.D., 2019. Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for…